Evidence map›Paper›PMID 35431604›Full record

ArticleTransportation research. Part E, Logistics and transportation review2022

Multi-period vaccine allocation model in a pandemic: A case study of COVID-19 in Australia.

Masih Fadaki, Ahmad Abareshi, Shaghayegh Maleki Far, Paul Tae-Woo Lee

Open access · greenAbstract read
In one paragraph

Article in Transportation research. Part E, Logistics and transportation review, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
7.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Pharmacy-based immunization: a systematic review.Frontiers in public health · 2023
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. A reliable emergency logistics network for COVID-19 considering the uncertain time-varying demands.Transportation research. Part E, Logistics and transportation review · 2023
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Masih FadakiDepartment of Supply Chain and Logistics Management, RMIT University, Melbourne, VIC 3000, Australia.
Ahmad AbareshiDepartment of Supply Chain and Logistics Management, RMIT University, Melbourne, VIC 3000, Australia.
Shaghayegh Maleki FarDepartment of Supply Chain and Logistics Management, RMIT University, Melbourne, VIC 3000, Australia.
Paul Tae-Woo LeeMaritime Logistics and Free Trade Islands Research Center, Ocean College, Zhejiang University, Zhoushan, China.
RMIT University · AUZhejiang Ocean University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While the swift development and production of a COVID-19 vaccine has been a remarkable success, it is equally crucial to ensure that the vaccine is allocated and distributed in a timely and efficient manner. Prior research on pandemic supply chain has not fully incorporated the underlying factors and constraints in designing a vaccine allocation model. This study proposes an innovative vaccine allocation model to contain the spread of infectious diseases incorporating key contributing factors to the risk of uninoculated people including susceptibility rate and exposure risk. Analyses of the data collected from the state of Victoria in Australia show that a vaccine allocation model can deliver a superior performance in minimizing the risk of unvaccinated people when a multi-period approach is employed and augmenting operational mechanisms including transshipment between medical centers, capacity sharing, and mobile units being integrated into the vaccine allocation model.

Indexed as

Allocation modelsCapacity sharingCOVID-19 pandemicMobile unitsMulti-period decision makingVaccine supply chain

Identifiers

PMID35431604
PMCPMC8995313
OpenAlexW4223539469

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.